Collection-image

TOPICAL COLLECTIONS

State-of-the-art and New Advancement for Organs Makers: 3D Tissue Engineering for Anatomical Components

Submit Abstract

Guest Editor

Matteo Ghiringhelli

Matteo Ghiringhelli

Technion-Israel Institute of Technology, The Rappaport Faculty of Medicine and Research Institute, Sohnis Research laboratory for Cardiac Electrophysiology and Regenerative Medicine

Matteo Ghiringhelli DVM, PhD is a post-doctoral student at the Bruce Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, in the Lior Gepstein’s Shonis Family Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine. In 2013, Dr. Ghiringhelli received his DVM from Università degli Studi di Milano. In the same institution he then obtained a PhD in Parenteral Nutrition and Liver Regeneration developing his expertise in organ decellularization/recellularization, organ perfusion and 3D cell cultured. Dr. Ghiringhelli practice veterinary medicine for the Veterinary Teaching Hospital of the Università degli Studi di Milano and specialized himself in small animal cardiothoracic surgery and cardio-pulmunary by-pass procedures under supervision of Professor Masami Uechi at the JASMINE medical center, Japan.    His research focuses on using tissue engineering and regenerative medicine methods and developmental biology data types to gain insight into heart regeneration and 3D in vivo modeling.

Collection Overview

Recent advances in three-dimensional (3D) techniques to grown and cultures multicellular structures have been expanded the futuristic concept of organ-on-a-bench. With the longer life span, increasing of the population and general demand of organ transplantation our species will crave more solutions for organ and tissue replacement. Tissue engineering is one of the scientific fields where answers are developed in the last decades such as organ decellularization and three-dimensional (3D) bioprinting. Both interdisciplinary techniques are applying the principles of engineering and of life science towards the development of biological substitutes that restore, maintain, or improve tissue or organ function. Decellularization and 3D bioprinting imply the use of specific cells from primary or not-primary cultures combined with scaffolds, holding the promise to replace patient’s tissues with living tissue designed and fabricated to meet the anatomical and genetics and defects. To date, a novel concept in tissue engineering is approaching the idea that not only the mechanical characteristics of the biomaterials are essential and important but also the spatial organization within the scaffold and cells created are crucial for the phenotypical expression of the new built tissue. Anatomical organ-on-a-bench are the next steps to fulfill the gap between the native mammalian's organs and artificial ones.

The goals of this Methods Collection are: (1) to assess the current state state-of-the-art protocols and methods in the field of organs decellularization/recellularization and 3D bioprinting; (2) to expose novels approaches in the fields such as Freeform Reversible Embedding of Suspended Hydrogels (FRESH) and vascularized/recellularized scaffolds in bioreactors cultures.

Articles

Decellularized Apple-Derived Scaffolds for Bone Tissue Engineering <em>In Vitro</em> and <em>In Vivo</em>
9:49

Decellularized Apple-Derived Scaffolds for Bone Tissue Engineering In Vitro and In Vivo

0 Views

•

Cited by 7

•

2024

•